Purchase Order 75D30121P10570
Award Date
4/2/21
Potential Completion Date
5/1/23
Potential Value
$266K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
State Of California Controllers Office
NAICS Category
611310 - Colleges, Universities, and Professional Schools
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Los Angeles, CA 90024, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention (CDC) awarded a $599,271 purchase order contract to the University of California, Los Angeles (UCLA), operating as the Office of Research Administration, as the prime contractor. The contract is for the CBBD PROJECT and will be performed in Los Angeles, California over a period of performance from January 24, 2022 to January 23, 2023. The pricing structure is firm fixed price. No subcontractors or additional context on products/services were...
The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a $94,327 firm fixed price purchase order by the Centers for Disease Control and Prevention (CDC) to conduct a study on the UCLA football program. As the prime contractor, UCLA will leverage its expertise and facilities in Los Angeles, California to perform the services. No set-aside designation was applied to this contract award. UCLA routinely supports government agencies through...
The U.S. Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to the University of California, Los Angeles (UCLA) for the "LEGACY FOR CHILDREN" project. The $145,000.08 contract, which had no set-aside designation, was completed on August 28, 2018. As the prime contractor, UCLA's Office of Research Administration division provided research, training, and program implementation services from its facilities in Los...
<p>The University of California, Los Angeles, doing business as the Office of Research Administration, was awarded a $749,507 definitive contract by the Centers for Disease Control and Prevention to extend the SwabSeq agnostic diagnostic platform. The contract has a start date of September 29, 2023 and end date of September 28, 2025, and utilizes a firm fixed price structure. Performance will take place in Los Angeles, California. No subcontractors were identified.</p>
The University of California, Los Angeles (UCLA), through its Office of Research Administration, has been awarded a $749,000.00 firm fixed-price contract by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract involves research and development for scalable sequencing approaches to detect novel pathogens, with a focus on next-generation sequencing-based diagnostic tools for respiratory RNA virus pathogens. The contract has...
This firm fixed-price purchase order was awarded by the U.S. Department of Health and Human Services (HHS) to the University of California, Los Angeles (UCLA) for $99,487.00 to provide California Health Interview Survey data for the National Healthcare Disparities program. The award has no set-aside designation and will be performed at UCLA's facilities in Los Angeles, California. UCLA is the prime contractor and there is no mention of any subcontractors. This award supports HHS's efforts to...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $975,000.08 firm fixed price contract to the University of California, Los Angeles (UCLA), doing business as the Office of Research Administration, to provide technical assistance and training for the Legacy for Children parent training curriculum. The contract has no set-aside designation. The purpose of the contract is for UCLA, which originally developed and implemented the Legacy...
The federal contract award HHSN261200544000C was granted by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the University of California, Los Angeles (UCLA), doing business as the Office of Research Administration. The contract is for the "CALIFORNIA HEALTH INTERVIEW SURVEY" with a ceiling value of $32,418,504.00. The contract is a definitive contract with a cost-no-fee pricing type, and has a completion date of...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $789,188 firm fixed-price definitive contract to The Regents of the University of California, San Francisco (UCSF) for a project titled "FY22 BAA TOPIC 7 - UCSF." This contract, which has no set-aside designation, will run through September 25, 2024. UCSF, a public academic medical center and research university, will perform the work through its Controller's Office division. As a leading recipient of National...
This federal contract award to the University of California, Los Angeles (UCLA) - doing business as the Office of Research Administration - is for a $4,265,733 cost-plus-fixed-fee definitive contract with the Centers for Disease Control and Prevention (CDC) to provide research services related to monkeypox (MPOX) immunogenicity and seroprevalence. The contract has an ultimate completion date of September 2, 2028 and was awarded on September 3, 2024 with no set-aside designation. UCLA, as a prime...